0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Peripheral Neuropathic Pain - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-141
Home | Market Reports | Health | Health Conditions | Pain Management
Peripheral Neuropathic Pain Epidemiology Forecast to 2028

Peripheral Neuropathic Pain - Epidemiology Forecast to 2028

Code: DELV-Epid-141
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Peripheral Neuropathic Pain - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Peripheral Neuropathic Pain epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Peripheral Neuropathic Pain Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Peripheral Neuropathic Pain in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Peripheral Neuropathic Pain outlook. It also includes the explanation of changing trends of epidemiology outlining the Peripheral Neuropathic Pain scenario.

Peripheral Neuropathic Pain Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Peripheral Neuropathic Pain thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Peripheral Neuropathic Pain explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Peripheral Neuropathic Pain Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Peripheral Neuropathic Pain

Key assessments
• Patient Segmentation in Peripheral Neuropathic Pain
• Peripheral Neuropathic Pain Risk & Burden
• Factors driving growth in a specific Peripheral Neuropathic Pain patient population

1. Report Introduction
2. Peripheral Neuropathic Pain Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Peripheral Neuropathic Pain in 2016
2.2. Patient Share Distribution of Peripheral Neuropathic Pain in 2028
3. Disease Background and Overview: Peripheral Neuropathic Pain
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Peripheral Neuropathic Pain in 7MM
4.3. Total Prevalent/ Incident Patient Population of Peripheral Neuropathic Pain in 7MM – By Countries
5. Epidemiology of Peripheral Neuropathic Pain by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Peripheral Neuropathic Pain
5.1.3. Sub-Type Specific cases of the Peripheral Neuropathic Pain *
5.1.4. Sex- Specific Cases of the Peripheral Neuropathic Pain *
5.1.5. Diagnosed Cases of the Peripheral Neuropathic Pain
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Peripheral Neuropathic Pain
5.4.3. Sub-Type Specific cases of the Peripheral Neuropathic Pain *
5.4.4. Sex- Specific Cases of the Peripheral Neuropathic Pain *
5.4.5. Diagnosed Cases of the Peripheral Neuropathic Pain
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Peripheral Neuropathic Pain
5.5.3. Sub-Type Specific cases of the Peripheral Neuropathic Pain *
5.5.4. Sex- Specific Cases of the Peripheral Neuropathic Pain *
5.5.5. Diagnosed Cases of the Peripheral Neuropathic Pain
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Peripheral Neuropathic Pain
5.6.3. Sub-Type Specific cases of the Peripheral Neuropathic Pain *
5.6.4. Sex- Specific Cases of the Peripheral Neuropathic Pain *
5.6.5. Diagnosed Cases of the Peripheral Neuropathic Pain
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Peripheral Neuropathic Pain
5.7.3. Sub-Type Specific cases of the Peripheral Neuropathic Pain *
5.7.4. Sex- Specific Cases of the Peripheral Neuropathic Pain *
5.7.5. Diagnosed Cases of the Peripheral Neuropathic Pain
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Peripheral Neuropathic Pain
5.8.3. Sub-Type Specific cases of the Peripheral Neuropathic Pain *
5.8.4. Sex- Specific Cases of the Peripheral Neuropathic Pain *
5.8.5. Diagnosed Cases of the Peripheral Neuropathic Pain
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Peripheral Neuropathic Pain
5.9.3. Sub-Type Specific cases of the Peripheral Neuropathic Pain *
5.9.4. Sex- Specific Cases of the Peripheral Neuropathic Pain *
5.9.5. Diagnosed Cases of the Peripheral Neuropathic Pain
6. Unmet Needs of the Peripheral Neuropathic Pain
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Table :

Table 1: Total Prevalent/Incident Cases of the Peripheral Neuropathic Pain in 7MM
Table 2: Total Prevalent/Incident Cases of the Peripheral Neuropathic Pain in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Peripheral Neuropathic Pain in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Peripheral Neuropathic Pain in United States (2016-2028)*
Table 6: Diagnosed Cases of the Peripheral Neuropathic Pain in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Peripheral Neuropathic Pain in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Peripheral Neuropathic Pain in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Peripheral Neuropathic Pain in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in France (2016-2028)
Table 12: Sub-Type Specific cases of the Peripheral Neuropathic Pain in France (2016-2028) *
Table 13: Sex- Specific Cases of the Peripheral Neuropathic Pain in France (2016-2028) *
Table 14: Diagnosed Cases of the Peripheral Neuropathic Pain in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Peripheral Neuropathic Pain in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Peripheral Neuropathic Pain in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Peripheral Neuropathic Pain in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Peripheral Neuropathic Pain in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Peripheral Neuropathic Pain in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Peripheral Neuropathic Pain in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Peripheral Neuropathic Pain in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Peripheral Neuropathic Pain in UK (2016-2028) *
Table 26: Diagnosed Cases of the Peripheral Neuropathic Pain in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Peripheral Neuropathic Pain in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Peripheral Neuropathic Pain in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Peripheral Neuropathic Pain in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Peripheral Neuropathic Pain in 7MM
Figure 2: Total Prevalent/Incident Cases of the Peripheral Neuropathic Pain in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Peripheral Neuropathic Pain in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Peripheral Neuropathic Pain in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Peripheral Neuropathic Pain in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Peripheral Neuropathic Pain in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Peripheral Neuropathic Pain in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Peripheral Neuropathic Pain in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Peripheral Neuropathic Pain in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Peripheral Neuropathic Pain in France (2016-2028) *
Figure 14: Diagnosed Cases of the Peripheral Neuropathic Pain in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Peripheral Neuropathic Pain in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Peripheral Neuropathic Pain in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Peripheral Neuropathic Pain in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Peripheral Neuropathic Pain in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Peripheral Neuropathic Pain in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Peripheral Neuropathic Pain in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Peripheral Neuropathic Pain in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Peripheral Neuropathic Pain in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Peripheral Neuropathic Pain in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Peripheral Neuropathic Pain in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Peripheral Neuropathic Pain in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Peripheral Neuropathic Pain in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Peripheral Neuropathic Pain in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global and Japan Joint Pain Injections Market Insights Forecast to 2027
Global and Japan Joint Pain Injections Market Insights, Forecast to 2027

Based on distribution channel the market has been segregated into hospital pharmacies retail pharmacies and online pharmacies.Market Analysis and Insights Global and Japan Joint Pain Injections MarketThis report focuses on global and Japan Joint Pain Injections market.In 2020 the global Joint Pain Injections market size was US 2768.5 million and it is expected to reach US 4013.6 million by the end of 2027 with a CAGR of 5.0 during 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-21F7416
Sat Nov 20 00:00:00 UTC 2021

Add to Cart

China Antipyretic Analgesics Market Report Forecast 2021 2027
China Antipyretic Analgesics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-20T5723
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global and Japan Ketorolac Injection Market Insights Forecast to 2027
Global and Japan Ketorolac Injection Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24Z7589
Wed Sep 22 00:00:00 UTC 2021

Add to Cart

Global Codeine Drug Market Size Status and Forecast 2021 2027
Global Codeine Drug Market Size, Status and Forecast 2021-2027

It is typically used to treat mild to moderate degrees of pain.Market Analysis and Insights Global Codeine Drug MarketIn 2021 the global Codeine Drug market size will be US million and it is expected to reach US million by the end of 2027 with a CAGR of during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Codeine Drug market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-29T7546
Tue Sep 21 00:00:00 UTC 2021

Add to Cart